Navigation Links
FDA Approves Genzyme's Renvela(TM) for Dialysis Patients
Date:10/22/2007

CAMBRIDGE, Mass., Oct. 22 /PRNewswire-FirstCall/ -- Genzyme Corp. (Nasdaq: GENZ) today announced that the U.S. Food and Drug Administration has granted marketing approval for Renvela(TM) (sevelamer carbonate) for the control of serum phosphorus in patients with chronic kidney disease on dialysis. Renvela is a next-generation version of Renagel(R) (sevelamer hydrochloride), the most-prescribed phosphate binder in the United States.

"Since its approval in 1998, Renagel has made an important difference for hundreds of thousands of patients around the world. Today's approval of Renvela -- an improved form of Renagel -- is a key milestone in our ongoing effort to innovate on behalf of patients," said John P. Butler, president, Genzyme Renal. "As we prepare to launch Renvela for patients on dialysis, we will move forward with regulatory filings to gain approval for the product's use in earlier stages of chronic kidney disease, so that all patients who can benefit from this treatment have access to it."

Like Renagel, Renvela is a calcium-free, metal-free, non-absorbed phosphate binder and will initially be available as 800mg tablets. Renvela offers all of the advantages of Renagel with the added benefit of a carbonate buffer. In a clinical study comparing Renvela to Renagel, both drugs controlled serum phosphorus equally to within KDOQI recommended ranges. Patients on Renvela, however, were more likely to maintain bicarbonate levels within the recommended KDOQI ranges, and had a lower incidence of gastrointestinal adverse events.

Genzyme expects to launch Renvela for dialysis patients in the United States during the first quarter of next year, and is pursuing regulatory approvals in Europe, South America an
'/>"/>

SOURCE Genzyme Corp.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. UW-Madison approves new research institute
2. FDA approves GEs heart-imaging technology
3. Senate approves bill to expand stem cell funding
4. FDA approves advanced digital mammography system
5. Building commission approves Institutes for Discovery
6. UW Board of Regents approves $134 million medical research facility
7. FDA approves Bone Cares Hectorol for treatment of kidney disease
8. Sensitive detection of tumor cells in peripheral blood of carcinoma patients by a reverse transcription PCR method
9. Quantitation of GAD67 Gene Expression in Prefrontal Cortex of Schizophrenia Patients Using the iCycler iQ Detection System and Molecular Beacons, Rev A
10. What patients want: A story of choice, clinical trials & evidence-based medicine
11. Heart patients benefit from digital image network

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/19/2009)..., , MUNSTER, Germany, November 19 /PR...they have filed on November 16th, 2009 Flibanserin...uced dyskinesia in Parkinson,s,disease for orphan ...s Agency,(EMEA). Levodopa-induced dyskinesia is a ... Parkinson,s and a serious burden to some of those...
(Date:11/19/2009)... Top LASIK surgeons and re...isted at Trusted LASIK Surgeons made brought their...ents in vision correction surgery, cataract surger...ncluded American Academy of Ophthalmology (AAO) an...hard Lindstrom, Dr. Shachar Tauber, Dr. David Huan...
(Date:11/19/2009)... InSound is honored by lat... Newark, CA (PRWEB) November 16, ...ic “invisible” hearing aid from InSoun...uo;s New Award in the Health category.  ...ic is designed to reside deep in the hearing canal...
(Date:11/18/2009)..., , DAVIS, Calif., Nov. 18 Ma...very, development and commercialization of effecti... products, announced that it has been named an IC2...tes, oldest and largest national angel investing g...erformance leading to rewarding results for all st...
Breaking Biology Technology:MONITORING FORCE GmbH Requests Acknowledgment of Flibanserin as "Orphan Drug" 2Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 2Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 3Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 4Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 5Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 6Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 7Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 8Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 9Popular Science Awards Lyric “Invisible” Hearing Aid 2009 “Best of What's New” Award 2Popular Science Awards Lyric “Invisible” Hearing Aid 2009 “Best of What's New” Award 3Marrone Bio Innovations Named an IC20 Company 2
... Feb. 26 BioVascular, Inc., a company focused,on ...ated diseases, today,announced that it appointed C... vice president of pharmaceutical operations and E...usiness development and nonvascular,operations., ...and experience to,BioVascular that will allow us t...
...Calif., Feb. 26 Ardea Biosciences,Inc. (Nasdaq: ...atory,disease Scientific Advisory Board (SAB). The...d counsel to the Company regarding key decisions,r...o treat chronic,inflammatory diseases, such as gou...ether a group of international authorities in gout...
... Industry Veteran to Head Rapid Sales Growth of Le...ement Developer, SANTA CLARA, Calif., Feb. 26 Ek...l radiography (DR), PACS (Picture Archiving and,Co...are (VIA(TM)) for,veterinary care practices, today...resident of worldwide sales. Royea is a long-time ...
Other Biology Technology:BioVascular, Inc. Expands Executive Team 2Ardea Biosciences Establishes Scientific Advisory Board for Inflammation Program 2Ardea Biosciences Establishes Scientific Advisory Board for Inflammation Program 3Royea Joins Eklin Medical Systems as VP of Worldwide Sales 2Royea Joins Eklin Medical Systems as VP of Worldwide Sales 3
(Date:11/20/2009)...hers are invited to contribute their abstracts to ...ECCEO10), the largest global meeting devoted to al...rch and patient care. The Congress will be held in... today, abstracts can be submitted online at http...dline is February 4, 2010. , IOF and ESCEO are p...
(Date:11/20/2009)...y question in the origin of biological molecules l...llions of years ago from simple precursors. Now, i...s in Italy have reconstructed one of the earliest ...RNA from individual subunits using nothing but war...s one of the first biological molecules present, b...
(Date:11/20/2009)...Toxic dust: Toxins in coal-tar-based sealcoats in ...use dust, according to a USGS study. PAHs or pol... found in oil, coal and tar deposits, and can have... often found in house dust; however, the specific ...searchers found that dust from indoor areas near p...
Breaking Biology News(10 mins):Special sessions announced for World Congress on Osteoporosis 2010 - IOF WCO - ECCEO10 2Special sessions announced for World Congress on Osteoporosis 2010 - IOF WCO - ECCEO10 3From toxic dust and algae to ill winds from Africa 2From toxic dust and algae to ill winds from Africa 3From toxic dust and algae to ill winds from Africa 4From toxic dust and algae to ill winds from Africa 5Immune responses to flu vaccine are diminished in lupus patients 53173 1Immune responses to flu vaccine are diminished in lupus patients 53173 2Nanoparticle delivered suicide genes slowed ovarian tumor growth 9423 1Nanoparticle delivered suicide genes slowed ovarian tumor growth 9423 2Reducing risk of hospitalization in the elderly 9421 1Reducing risk of hospitalization in the elderly 9421 2
...s more evidence that a brief bout of stress can gi...tain conditions. , Laboratory results showed that...urs ?temporarily mobilized all major types of immu...ns in the body. In certain situations, this stress...e advantageous, as leukocytes fight infections and...
...ew hundred thousand years after our putative moder...f archaic humans crossed the Bering land bridge fr...ence support this model, but that,s where the cons... paper published in the premier open-access journa... of the first New World populations have changed s...
...YSE: A) today announced that it has for the first ...annotation information for all of its microarrays....prove cross-laboratory experimental research and c...the probe sequences is an admirable and responsibl...ll, president of the Microarray Gene Expression Da...
Other Biology News:A little stress gives beneficial oomph! to immune system 2A little stress gives beneficial oomph! to immune system 3New World founders small in number 2Agilent Technologies releases probe sequence, annotation information for all its commercial gene expression microarrays 2
GIBCO Porcine Serum from Invitrogen
Human Antibody Array I Kit, RayBio L Series 507: RayBio Label-based from Raybiotech, Inc.
AlleleID from PREMIER Biosoft International
Mouse GM-CSF ELISpot Development Kit from R&D Systems
Biology Products: